Pacific Edge Limited

Pacific Edge Biotechnology Limited

Jan Friederichs

Michael Alan Black

Anthony Edmund Reeve

Robert Craig Pollock

Hjalmar Nekarda

Bernhard Holzmann

John Lindsay McCall

Robert Rosenberg

Yu-Hsin Lin

John Lindsay Mccall

This invention relates to prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for colorectal cancer. Specifically, this invention relates to the use of genetic markers for the prediction of the prognosis of cancer, such as colorectal cancer based on signatures of genetic markers. In various aspects, the invention relates to a method of predicting the likelihood of long-term survival of a cancer patient, a method of determining a treatment regime for a cancer patient, a method of preparing a treatment modality for a cancer patient, among other methods as well as kits and devices for carrying out these methods.

Methods for treating colorectal cancer using prognostic genetic markers

This invention relates to prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for colorectal cancer. Specifically, this invention relates to the use of genetic markers for the prediction of the prognosis of cancer, such as colorectal cancer, based on signatures of genetic markers. In various aspects, the invention relates to a method of predicting the likelihood of long-term survival of a cancer patient, a method of determining a treatment regime for a cancer patient, a method of preparing a treatment modality for a cancer patient, among other methods as well as kits and devices for carrying out these methods.

Growing community of inventors

Munich, Germany

Jan Friederichs